Xeris Pharmaceuticals | Ventes



Sales Changement Date
Adcock Ingram Holdings ZAR 4.9B 162.28M 2024-06
Celltrion KRW 1.06T 181.72B 2024-12
Cspc Pharmaceutical CNY 6.32B 78.77M 2024-12
Dianthus Therapeutics USD 1.33M 846K 2024-12
Ecofibre AUD 7.63M 1.27M 2024-06
Eli Lilly USD 13.53B 2.09B 2024-12
Kangmei Pharma CNY 1.4B 126.12M 2024-09
Knight Therapeutics CAD 92.26M 3.31M 2024-09
Laboratorios Farma 434.41M 256.25M 2024-12
Malin Corporation EUR 19.2M 2.6M 2020-12
Medical Developments International AUD 7.54M 0 2023-12
Neuren Pharmaceuticals AUD 194.1M 163.93M 2024-12
Organigram Holdings CAD 42.73M 1.97M 2024-12
Pacira USD 187.25M 18.68M 2024-12
Perrigo USD 1.14B 50.8M 2024-12
Pharma Mar EUR 48.36M 2.71M 2024-12
Qiagen NV USD 499.93M 32.58M 2024-12
Sartorius EUR 907M 113.4M 2024-12
Sino Biopharmaceutical CNY 15.87B 592.96M 2024-06
Supernus Pharmaceuticals USD 174.16M 1.53M 2024-12
Tilray USD 264.23M 53.28M 2025-03
Zhangzhou Pientzehuang Pharmaceutical 2.8B 320M 2024-09



Xeris Pharmaceuticals Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.